Ethanol versus polidocanol for ultrasound-guided sclerotherapy of benign thyroid cysts: a prospective randomized study

Abstract Background Benign thyroid cysts are common lesions that may cause compressive symptoms or cosmetic concerns. Surgery is a definitive treatment but carries potential risks. Simple aspiration has been associated with high recurrence rates, while ultrasound-guided percutaneous sclerotherapy using agents such as ethanol and polidocanol has emerged as a minimally invasive alternative with high success rate, we aimed to compare the safety and efficacy of ultrasound-guided percutaneous ethanol injection versus polidocanol injection in the management of benign thyroid cysts. Methods In this prospective randomized study, 30 patients with symptomatic benign thyroid cysts were treated with either 99% ethanol or 20% polidocanol under ultrasound guidance. Procedural parameters, complications, and pain scores using the visual analog scale (VAS) were recorded. After aspiration/sclerotherapy, the clinical and sonographic follow-up was performed at 1, 3, and 6 months. Clinical success was defined as ≥ 50% reduction in cyst volume with associated improvement of symptoms. Results Both groups demonstrated comparable technical and clinical success. Mean cyst volume reduction at 6 months exceeded 96% in both groups, with no statistically significant difference ( p > 0.05). Improvement in compressive and cosmetic symptoms was similar (92.9% in the ethanol group vs. 100% in the polidocanol group; p = 0.292). Procedural pain was significantly lower in the polidocanol group (VAS 2.87 ± 1.46) compared to the ethanol group (VAS 5.0 ± 1.0; p < 0.001). Thyroid function remained stable in both groups throughout follow-up. Residual cysts and the need for repeat sessions were more frequent in the polidocanol group (21.4% vs. 0%), approaching statistical significance ( p = 0.058). Conclusions Ultrasound-guided sclerotherapy using either ethanol or polidocanol is safe and effective for the treatment of benign thyroid cysts. Both agents give substantial volume reduction and symptom relief. Polidocanol is associated with significantly less procedural pain, whereas ethanol demonstrates a trend toward lower recurrence rates.

Authors

Institutions

Publication Details

Journal
The Egyptian Journal of Radiology and Nuclear Medicine
Published
2026-11-16
DOI
https://doi.org/10.1186/s43055-026-01916-8
Primary Topic
Thyroid Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Ethanol versus polidocanol for ultrasound-guided sclerotherapy of benign thyroid cysts: a prospective randomized study

Sayed Hassan Ahmed Hassaneen, M.A. Seif Hany, Amna Ahmed Ali, Mohamed A. Rizk et al.
2 links
The Egyptian Journal of Radiology and Nuclear Medicine
Thyroid Cancer Diagnosis and Treatment
article

Ethanol versus polidocanol for ultrasound-guided sclerotherapy of benign thyroid cysts: a prospective randomized study

Sayed Hassan Ahmed Hassaneen, M.A. Seif Hany, Amna Ahmed Ali, Mohamed A. Rizk, Marwa Makboul
article en

Abstract

Abstract Background Benign thyroid cysts are common lesions that may cause compressive symptoms or cosmetic concerns. Surgery is a definitive treatment but carries potential risks. Simple aspiration has been associated with high recurrence rates, while ultrasound-guided percutaneous sclerotherapy using agents such as ethanol and polidocanol has emerged as a minimally invasive alternative with high success rate, we aimed to compare the safety and efficacy of ultrasound-guided percutaneous ethanol injection versus polidocanol injection in the management of benign thyroid cysts. Methods In this prospective randomized study, 30 patients with symptomatic benign thyroid cysts were treated with either 99% ethanol or 20% polidocanol under ultrasound guidance. Procedural parameters, complications, and pain scores using the visual analog scale (VAS) were recorded. After aspiration/sclerotherapy, the clinical and sonographic follow-up was performed at 1, 3, and 6 months. Clinical success was defined as ≥ 50% reduction in cyst volume with associated improvement of symptoms. Results Both groups demonstrated comparable technical and clinical success. Mean cyst volume reduction at 6 months exceeded 96% in both groups, with no statistically significant difference ( p > 0.05). Improvement in compressive and cosmetic symptoms was similar (92.9% in the ethanol group vs. 100% in the polidocanol group; p = 0.292). Procedural pain was significantly lower in the polidocanol group (VAS 2.87 ± 1.46) compared to the ethanol group (VAS 5.0 ± 1.0; p < 0.001). Thyroid function remained stable in both groups throughout follow-up. Residual cysts and the need for repeat sessions were more frequent in the polidocanol group (21.4% vs. 0%), approaching statistical significance ( p = 0.058). Conclusions Ultrasound-guided sclerotherapy using either ethanol or polidocanol is safe and effective for the treatment of benign thyroid cysts. Both agents give substantial volume reduction and symptom relief. Polidocanol is associated with significantly less procedural pain, whereas ethanol demonstrates a trend toward lower recurrence rates.

The Egyptian Journal of Radiology and Nuclear MedicineVol. 57(1)
Assiut University (EG)
Good health and well-being
Thyroid Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon